Last updated: 9 November 2021 at 5:43pm EST

Steven Meehan Net Worth



Steven Meehan biography

Steven Meehan serves as Chief Financial Officer, Executive Vice President of the Company.Prior to being named CFO, Mr. Meehan served as a director on our Board since 2017. Mr. Meehan has over 25 years of investment banking experience. Mr. Meehan was a Partner in the Healthcare Group of Moelis & Company from 2011 through 2016, leading the effort in Life Sciences and Advanced Diagnostics. Additionally, Mr. Meehan was previously the Head of Life Sciences within the Global Healthcare Group in the New York office of UBS Investment Bank (“UBS”). Mr. Meehan was also part of the team that formed the Healthcare Group at UBS in 1999. During Mr. Meehan’s tenure at UBS, he was Chief Executive Officer of UBS Russia and CIS across all businesses including securities, banking and wealth management. Mr. Meehan was also a member of the UBS Group EMEA Management Committee. During his investment banking career, Mr. Meehan also held senior roles in M&A, leveraged finance and capital markets at Salomon Smith Barney, NatWest Securities and Drexel Burnham Lambert. Mr. Meehan holds a B.S. in Business Administration/Finance from the University of Massachusetts at Lowell.

What is the salary of Steven Meehan?

As the Chief Financial Officer、 Executive Vice President of Kadmon Inc, the total compensation of Steven Meehan at Kadmon Inc is 1,288,240$. There are 1 executives at Kadmon Inc getting paid more, with Harlan Waksal having the highest compensation of 4,742,770$.



How old is Steven Meehan?

Steven Meehan is 55, he's been the Chief Financial Officer、 Executive Vice President of Kadmon Inc since 2019. There are 6 older and 3 younger executives at Kadmon Inc. The oldest executive at Kadmon Holdings Inc is Eugene Bauer, 77, who is the Independent Director.

What's Steven Meehan's mailing address?

Steven's mailing address filed with the SEC is C/O KADMON HOLDINGS, INC., 450 E. 29TH STREET, NEW YORK, NY, 10016.

Insiders trading at Kadmon Inc

Over the last 8 years, insiders at Kadmon Inc have traded over 7,020,661$ worth of Kadmon Inc stock and bought 7,084,916 units worth 54,943,934$ . The most active insiders traders include Advisors Llcperceptive Life...Asset Management Lp Golden ...Daniel S Third Point Llc Loeb. On average, Kadmon Inc executives and independent directors trade stock every 29 days with the average trade being worth of 1,948,175$. The most recent stock trade was executed by Harlan Waksal on 13 March 2020, trading 16,000 units of KDMN stock currently worth 46,880$.



What does Kadmon Inc do?

Kadmon is a clinical-stage biopharmaceutical company that discovers, develops and delivers transformative therapies for unmet medical needs. Its clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies.



What does Kadmon Inc's logo look like?

Kadmon Holdings Inc logo

Kadmon Inc executives and stock owners

Kadmon Inc executives and other stock owners filed with the SEC include: